Volume 11, Number 12—December 2005
Research
Antimicrobial-drug Susceptibility of Human and Animal Salmonella Typhimurium, Minnesota, 1997–2003
Table 2
Clonal group† | No. isolates by resistance phenotype |
||||||
---|---|---|---|---|---|---|---|
At least ACSSuT‡ | At least AKSSuT‡ | At least ACKSSuT | Other resistance phenotypes | Pansusceptible isolates | Total | ||
Human isolates | |||||||
Clonal group A | 169 | 1 | 12 | 27 | 8 | 217 | |
Clonal group B | 1 | 51 | 1 | 23 | 5 | 81 | |
Other | 22 | 12 | 12 | 124 | 560 | 730 | |
Total | 192 | 64 | 25 | 174 | 573 | 1,028 | |
Animal isolates | |||||||
Clonal group A | 182 | 3 | 67 | 10 | 2 | 264 | |
Clonal group B | 1 | 227 | 21 | 27 | 2 | 278 | |
Other | 21 | 20 | 23 | 38 | 72 | 174 | |
Total | 204 | 250 | 111 | 75 | 76 | 716 |
*PFGE, pulsed-field gel electrophoresis; A, ampicillin; C, chloramphenicol; K, kanamycin; S, streptomycin; Su, sulfisoxazole; T, tetracycline.
†Clonal groups are composed of subtypes that are <3 bands different from PFGE subtype TM5b (clonal group A) or <3 bands different from subtype TM54 (clonal group B).
‡Does not include ACKSSuT.
Page created: February 02, 2012
Page updated: February 02, 2012
Page reviewed: February 02, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.